65 results
8-K
EX-99.1
KRYS
Krystal Biotech Inc
7 Aug 23
Krystal Biotech Announces Second Quarter 2023 Financial Results and
7:13am
patients. The Phase 2 cohort will enroll both pediatric and adult patients with TGM1 deficient autosomal recessive congenital ichthyosis for assessment
8-K
EX-99.2
2y6gh7g6r
26 Jul 23
Krystal Biotech Announces Pipeline Expansion into Oncology
4:01pm
S-3ASR
9ubtfx jho
18 Jul 23
Automatic shelf registration
4:05pm
8-K
EX-10.1
h9m6bjm7dro8
22 May 23
Krystal Biotech Announces $160 Million Private Placement Equity Financing
7:32am
8-K
EX-1.1
6yzuz6nohs3vgg jq
8 May 23
Entry into a Material Definitive Agreement
8:51am
424B5
grqc3e0
8 May 23
Prospectus supplement for primary offering
8:48am
8-K
EX-99.1
gv97yyxb4p ptk
8 May 23
Krystal Biotech Announces First Quarter 2023 Financial Results and Rare dermatological pipeline
8:27am
S-3ASR
sduejb
6 Apr 23
Automatic shelf registration
4:43pm
8-K
EX-99.2
60rnwlattlgv0gue5to7
17 Nov 22
Regulation FD Disclosure
8:33am
8-K
EX-99.1
agdg jwyohvxwvkq
3 Nov 22
Regulation FD Disclosure
4:52pm